Application Nr Approved Date Route Status External Links
ANDA078420 2008-09-24 Oral DISCN Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Carefully Consider The Potential Benefits And Risks Of Nabumetone Tablets And Other Treatment Options Before Deciding To Use Nabumetone Tablets. Use The Lowest Effective Dose For The Shortest Duration Consistent With Individual Patient Treatment Goals (see Warnings). Nabumetone Tablets Are Indicated For Relief Of Signs And Symptoms Of Osteoarthritis And Rheumatoid Arthritis.

All Formulated Excipients (3 Total)

Name Structure Kind Function Status
1. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
2. Sodium Lauryl Sulfate SODIUM LAURYL SULFATE Molecular AF-Antifoaming (or defoaming) agent , CTG-Component or coating , EMUL-Emulsifier , SANI-Sanitizing agent , SDA-Solubilizing & dispersing agent REG-Food additives for which a petition has been filed and a regulation issued.
3. Polyethylene Glycol 400 POLYETHYLENE GLYCOL 400 Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Nabumetone NABUMETONE ZINC20221

Comments